Turkish Version of Telehealth Usability Questionnaire (TUQ)
Launched by IREM HÜZMELI · Mar 14, 2021
Trial Information
Current as of June 02, 2025
Completed
Keywords
ClinConnect Summary
The Telehealth Usability Questionnaire (TUQ) turkish version will be asked by using google forms to participants whom use telehealth.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Participants will undergo screening to confirm eligibility, completion of initial screening form, and MMSE evaluation. Study subjects were enrolled with MMSE scores between 29-30, inclusive (healthy/control), 25-28, inclusive (mild cognitive impairment), and 10-24 (dementia).
- • -
- Exclusion Criteria:
- • Unable to complete computerized and standard pencil-and-paper based assessments
About Irem Hüzmeli
irem hüzmeli is a dedicated clinical trial sponsor focused on advancing medical research and innovation across various therapeutic areas. Committed to enhancing patient outcomes, the organization collaborates with healthcare professionals, research institutions, and regulatory bodies to conduct high-quality clinical trials. With a strong emphasis on ethical standards and rigorous methodologies, irem hüzmeli aims to facilitate the development of safe and effective treatments while fostering a culture of transparency and collaboration in the clinical research community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hatay, Merkez, Turkey
Hatay, , Turkey
Patients applied
Trial Officials
Irem Huzmeli, Phd
Study Director
Mustafa Kemal University
Esra Dogru Huzmeli, Assoc Prof.
Principal Investigator
Mustafa Kemal University
Mehmet Karadağ, Asist. Prof.
Study Chair
Mustafa Kemal University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials